|
Gangliosidoses, GM2
|
C16.320.565.398.641.803.350.300 |
|
|
Amino Acid Transport Systems, Acidic
|
D12.776.543.585.200.249 |
|
|
Cystocele
|
C13.351.968.829.508 |
|
|
Glycogen Storage Disease Type VIII
|
C18.452.648.202.449.620 |
|
|
Glycogen Storage Disease
|
C18.452.648.202.449 |
|
|
Scotoma
|
D012607 |
[A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA), OPTIC NERVE DISEASES, and other conditions.
, A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions.
] |
|
Sulfathiazole
|
D03.383.129.708.725.500 |
|
|
Sulfathiazoles
|
D03.383.129.708.725 |
|
|
Scrapie
|
D012608 |
[A fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.
] |
|
Farber Lipogranulomatosis
|
C18.452.648.595.554.825.250 |
|
|
Charles Bonnet Syndrome
|
C10.597.606.762.300.500 |
|
|
Euthanasia
|
N02.421.585.905.199 |
|
|
RNA-Induced Silencing Complex
|
D12.776.157.725.500.906 |
|
|
Standard of Care
|
N04.761.789.900 |
|
|
Quality Indicators, Health Care
|
N04.761.789 |
|
|
Strongylida
|
B01.050.500.500.294.400.968 |
|
|
Gas Chromatography-Mass Spectrometry
|
E05.196.566.500 |
|
|
Scoliosis
|
D012600 |
[An appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed)
] |
|
Scopolamine
|
D012601 |
[An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic.
] |
|
G-Protein-Coupled Receptor Kinase 5
|
D12.776.476.293.875 |
|
